Navigation Links
Ingenious Med Hires New CEO to Maintain and Further Expand Company Development
Date:12/2/2008

ATLANTA, Dec. 2 /PRNewswire/ -- Ingenious Med (IM) welcomes new CEO, S. Hart Williford. Williford joins IM, the leader in inpatient practice management solutions, with an extensive background as a leader in healthcare, software, revenue management, medical services, sales, and digital media.

Founder and nine-year CEO, Dr. Steven Liu, is confident Williford will enhance the company's success and development in all sectors, as he steps into the role. Liu, a successful hospitalist and businessman, will remain chairman of the board and CMO. He gladly brings Williford in as CEO to shepherd IM through rapid growth and evolving opportunities.

"I searched for the perfect person to take my place as CEO and was impressed by Hart Williford's extensive experience," said Liu. "He is an exceptional businessman and a genuinely good person. He's quite accomplished at taking companies at our current stage and launching them to the next level, and we are very excited to have him."

Williford comes to IM from Memorial University Medical Center (Memorial) in Savannah where he served on the board and as Senior Vice President. His responsibilities included involvement with Memorial's Cancer Institute, IT, marketing and strategic planning, foundation and office-sponsored programs, business development and physician relations and recruitment. Memorial is a two-state, 35-county hospital with more than 530 beds and $800 million in revenue.

Williford's business profile also includes senior management positions from Boston to Hong Kong with companies such as VeriSign Corporation, IBM, AT&T and Digital Equipment Corporation. Relative past successes include H.O. Systems' (a software company serving the cell phone industry) growth from $16 million to over $120 million between 1999 and 2002 under Williford's lead. This dramatic growth led to an acquisition by VeriSign, while achieving record-high custo
'/>"/>

SOURCE Ingenious Med
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Ingenious Med Adds Specialists to Clientele, Cardiovascular Group
2. Ingenious Med Continues Record Customer Growth and Approaches Key Milestones
3. Ingenious Meds IM Quality Measures(TM) Delivers Insight About Hospitalist Performance
4. Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM
5. Ingenious Med Reports Record Sales and Client Expansions in 2007
6. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
7. A Place for Mom Hires Former VP of Sales and Marketing of Assisted Living Concepts as Market Development Coach
8. MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC
9. Pennsylvania Patient Safety Authority Hires Director of Educational Programs
10. PolyRemedy Hires Gary Coughlen as CFO
11. Washington Dental Service Hires New Eastern Washington Sales Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...t kit called DrugConfirm™ ,is the ideal drug... and accurate instant drug test. Developed by Biot...ek, innovative design and incorporates new Push Bu...y priced compared to the other urine cup products ... San Diego (Vocus) – A n...
(Date:7/3/2009)...home medical services provider specializing in inf...ervices, is expanding. Two new pharmacies in Roche...sion therapy and one in oral medication, a new pro... Clinton, NY (PRWEB) June 22, 2009 -- Ups...pecializing in infusion, specialty medication, res...
(Date:7/2/2009)...swire/ -- Acetaminophen is an ingredient found in ...o help relieve pain and reduce fever. Many people...nd prescription brand names, Vicodin and Percocet....June 30, 2009 to address liver related injuries du...d 20-17 to urge the FDA to put a ban on Vicodin an...
(Date:7/2/2009)..., expert says , , THURSDAY, July 2 (Heal... species of wildlife, which need to be protected t...ancer is one of the leading health concerns for hu... deaths. But we now understand that cancer can kil...se McAloose, chief pathologist for the Wildlife Co...
Breaking Medicine News(10 mins):Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Cancer Endangers Some Wildlife Species 2
...s have identified the receptor pathway used by est...morrhage//. The related report by Hsieh et al, “G ...se A pathway is critical in nongenomic effects of ...-hemorrhage,” appears in the April issue of The Am...
...proximately 20% of children with Acute Lymphoblast...ir disease following treatment//. Of these, most w...t these relapses were due to small numbers of cell...ent administered to the patient," said Prof Norris...
...s no additional effect when given to depressed peo... mood stabilizer//, according to a recent study. ...e Systematic Treatment Enhancement Program for Bip...on clinical trial funded by the National Institute...
...ople whose diets contain dramatically more of one ...y be at greater risk// for both clinical depressio...published online this week in the journal Psychoso...to balance out our intake of omega-6 and omega-3 f...
Other Medicine News:Health News:Estrogen Protects Liver After Traumatic Injury 2Health News:Antidepressant Medication Has No Effect on Bipolar Patients 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 3
(Date:6/30/2009)... Pa., June 30 Cephalon, ... submitted a supplemental New Drug Application (sN... requesting approval of NUVIGIL(R) (armodafinil) T...ulness in patients with excessive sleepiness assoc...nd travel. Jet lag disorder is an acute condition...
(Date:6/29/2009)...tive Study Seeks to Assess RSV Burden in Outpatien...ommitment to Pediatric Research , , GAITHERSB...ues to advance its commitment to pediatric researc...onal prospective study designed to assess the burd...erm infants 32-to-35 weeks gestational age (GA) in...
(Date:6/29/2009)...arma Targets for Novel Biotherapeutics Based On Na...O, June 29 Pangu BioPharma, a subs...d the filing of its third patent application on pr...A synthetases. Although tRNA synthetases are univ...s machinery found in all organisms, human syntheta...
(Date:6/28/2009)...MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire/...ed that add-on treatment with the novel,once-dai...tate; ESL) resulted,in a marked and sustained dec..., Results from the one-year extension of a ...ere presented at the International Congress for Ep...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 1Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 2Daiichi Sankyo Inc Announces Three Studies of Oral Factor Xa Inhibitor DU 176b Accepted for the 50th Annual Meeting of the American Society of Hemat 31007 3eResearchTechnology Inc to Present at the Piper Jaffray Health Care Conference on December 2 2008 9454 1eResearchTechnology Inc to Present at the Piper Jaffray Health Care Conference on December 2 2008 9454 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 1Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality Clinical Trial Research and Physician Patient Relationship 9452 4 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale Up for New Bio based Product 9451 1 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale Up for New Bio based Product 9451 2
Grooved roller, on which knife oscillates.
Disposable. For use with the N4086.
30 mm button end blade. Flat handle.
5 mm small, sharp, protected blade. Angled at 105 degrees. Flat handle. Designated most popular model or size.
Medicine Products: